AA
MIST icon

Ancora Advisors’s Milestone Pharmaceuticals MIST Stock Holding History

Ancora Advisors’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$11.9K – 2227
2026
Q1 		$11.9K Hold
10,000
– – ﹤0.01% 1733
2025
Q4 		$20.2K Hold
10,000
– – ﹤0.01% 1559
2025
Q3 		$20K Hold
10,000
– – ﹤0.01% 1243
2025
Q2 		$19.4K Hold
10,000
– – ﹤0.01% 1237
2025
Q1 		$8K Hold
10,000
– – ﹤0.01% 1348
2024
Q4 		$23.6K Sell
10,000
-50,000
-83% -$85.8K ﹤0.01% 1179
2024
Q3 		$91.2K Hold
60,000
– – ﹤0.01% 839
2024
Q2 		$79.2K Hold
60,000
– – ﹤0.01% 853
2024
Q1 		$107K Buy
60,000
+10,000
+20% +$16.2K ﹤0.01% 790
2023
Q4 		$83.5K Buy
+50,000
New +$136K ﹤0.01% 832

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Ancora Advisors's MIST Position: Q2 2026 in Review

Ancora Advisors sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 10,000 shares — an estimated $11.9K sold.

Ancora Advisors first reported a position in MIST in Q4 2023 and held it in 10 quarters. The position peaked at $107K in Q1 2024. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Ancora Advisors reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Ancora Advisors sold 10,000 Milestone Pharmaceuticals shares in Q2 2026, an estimated $11.9K.
  • Ancora Advisors first reported a position in Milestone Pharmaceuticals in Q4 2023 and held it in 10 quarters.
  • Ancora Advisors's Milestone Pharmaceuticals position peaked at $107K in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.